Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shares notification

31 Jan 2007 09:37

ReNeuron Group plc31 January 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer RENEURON GROUP PLCof existing shares to which voting rights are attached 2. Reason for the notification (please tick the appropriate box or boxes)An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which rioting rights are attached An event changing the breakdown of voting rights 3. Full name of person(s) subject to the SAAD INVESTMENTS COMPANY LIMITED notification obligation4. Full name of shareholder(s) (if different from 3.) Vidacos Nominees Ltd (Citigroup Global AWAL)5. Date of the transaction and date on which the Not specified. threshold is crossed or reached6. Date on which issuer notified 30 January 2007 A: Voting rights attached to sharesClass/type Situation Resulting situation after the triggering transaction vi of shares previous to the Triggering if possible transactionusing the ISIN Number of Number Number of Number of voting rights % of voting rightsCODE Shares shares ix of Voting Rights Direct Direct Indirect Direct Indirect Ordinary Shares Not Not 18,950,000 18,950,000 0 15.988% 0 specified specified B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration Exercise/Conversion Number of voting rights % of voting date Period/Date that may be acquired if rightsinstrument the instrument is - exercised/converted N/A - - - - Total (A+B)Number of voting rights % of voting rights 18,950,000 15.988% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable None specified. Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A12. Date on which proxy holder will cease to hold voting N/Arights: 13. Additional information: Recent acquisition. 14. Contact name: Michael Hunt, CEO15. Contact telephone number: 01483 302560 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Oct 20217:00 amRNSDirector/PDMR Interest in Share Options
18th Oct 20217:00 amRNSFurther changes in the Board of Directors
18th Oct 20217:00 amRNSFirst subject treated at Oxford Eye Hospital
12th Oct 20212:05 pmRNSSecond Price Monitoring Extn
12th Oct 20212:01 pmRNSPrice Monitoring Extension
11th Oct 20214:40 pmRNSSecond Price Monitoring Extn
11th Oct 20214:35 pmRNSPrice Monitoring Extension
11th Oct 20212:06 pmRNSSecond Price Monitoring Extn
11th Oct 20212:00 pmRNSPrice Monitoring Extension
11th Oct 202111:05 amRNSSecond Price Monitoring Extn
11th Oct 202111:00 amRNSPrice Monitoring Extension
11th Oct 20219:05 amRNSSecond Price Monitoring Extn
11th Oct 20219:00 amRNSPrice Monitoring Extension
11th Oct 20217:00 amRNSPositive data generated in exosome collaboration
1st Oct 20217:00 amRNSRegulatory approval for continuation of RP trial
16th Sep 20214:26 pmRNSResult of AGM
2nd Sep 202112:00 pmRNSBlock Listing Review, Application and TVR
16th Aug 20212:20 pmRNSPosting of AR and Accounts and Notice of AGM
6th Aug 20217:00 amRNSDirectorate Change
14th Jul 20217:00 amRNSBoard Change
8th Jul 20217:00 amRNSPreliminary Results for the year ended 31 March 21
2nd Jul 20211:00 pmRNSNotice of Results
2nd Jul 20217:00 amRNSNotice of Results
1st Jul 20217:00 amRNSDirectorate Change
1st Jul 20217:00 amRNSTotal Voting Rights
18th Jun 202110:48 amRNSHolding(s) in Company
9th Jun 20214:36 pmRNSPrice Monitoring Extension
9th Jun 20212:05 pmRNSSecond Price Monitoring Extn
9th Jun 20212:00 pmRNSPrice Monitoring Extension
9th Jun 202111:55 amRNSUpdate for hRPC therapy candidate study
7th Jun 20215:25 pmRNSHolding(s) in Company
20th May 20217:00 amRNSAppointment of Chief Scientific Officer
4th May 20217:00 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSInitiation of research by Allenby Capital
6th Apr 20217:00 amRNSVirtual conference attendance and presentations
30th Mar 20217:00 amRNSHolding(s) in Company
19th Mar 20217:00 amRNSExosome platform update
16th Mar 20214:05 pmRNSHolding(s) in Company
16th Mar 202110:57 amRNSHolding(s) in Company
16th Mar 20217:00 amRNSHolding(s) in Company
12th Mar 20217:00 amRNSDirectorate Change
1st Mar 20217:00 amRNSBlock Listing Review and Total Voting Rights
25th Feb 20217:01 amRNSInvestor presentations
25th Feb 20217:00 amRNSAppointment of Joint Broker
11th Feb 20217:00 amRNSDirector/PDMR Interest in Shares and Share Options
1st Feb 20219:55 amRNSTotal Voting Rights
15th Jan 20212:06 pmRNSSecond Price Monitoring Extn
15th Jan 20212:01 pmRNSPrice Monitoring Extension
15th Jan 20217:00 amRNSClinical Update
6th Jan 20217:00 amRNSAnalyst Conference Call

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.